Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free ARAY Stock Alerts

Accuray (ARAY) Financials

Accuray logo
$0.24 0.00 (-0.17%)
As of 09:05 AM Eastern
Compare
Annual Income Statements for Accuray

Annual Income Statements for Accuray

This table shows Accuray's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Income / (Loss) Attributable to Common Shareholders		 -40 -26 -30 299 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59
Consolidated Net Income / (Loss)		 -40 -26 -30 -24 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59
Net Income / (Loss) Continuing Operations		 -40 -26 -30 299 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59
Total Pre-Tax Income 		-38 -23 -29 -23 -14 5.69 -4.56 -2.00 -6.79 -12 1.13
Total Operating Income		 -19 -4.87 -9.82 -3.80 0.58 13 22 8.15 2.38 0.50 7.84
Total Gross Profit		 145 159 141 323 163 150 160 160 154 143 147
Total Revenue		 380 399 383 810 419 383 396 430 448 447 459
Operating Revenue		 380 399 383 810 419 383 396 430 448 447 459
Total Cost of Revenue		 234 240 242 486 256 233 237 270 294 304 312
Operating Cost of Revenue		 234 240 242 486 256 233 237 270 294 304 312
Total Operating Expenses		 165 164 151 3.80 162 137 137 152 152 142 139
Selling, General & Admin Expense		 46 50 44 48 50 40 42 44 48 50 48
Marketing Expense		 62 57 57 60 56 47 43 50 46 43 43
Research & Development Expense		 56 57 50 57 56 50 53 58 57 50 48
Total Other Income / (Expense), net		 -19 -18 -19 -19 -15 -6.85 -27 -10 -9.17 -12 -6.71
Interest Expense		 - - - - - - - 8.13 11 12 11
Interest & Investment Income		 - - - 0.00 0.00 -0.15 0.87 0.24 2.57 1.84 4.71
Other Income / (Expense), net		 -19 -18 -19 -19 -15 -6.70 -28 -2.26 -1.11 -2.54 0.06
Income Tax Expense		 2.42 2.34 1.04 0.88 2.09 1.86 1.75 3.35 2.49 3.73 2.73
Basic Earnings per Share		 ($0.51) ($0.32) ($0.36) ($0.28) ($0.19) $0.04 ($0.07) ($0.06) ($0.10) ($0.16) ($0.02)
Weighted Average Basic Shares Outstanding		 78.28M 80.51M 82.50M 84.89M 87.47M 89.87M 92.03M 92.10M 94.88M 98.27M 102.77M
Weighted Average Diluted Shares Outstanding		 78.28M 80.51M 82.50M 84.89M 87.47M 90.62M 92.03M 92.10M 94.88M 100.27M 112.68M
Weighted Average Basic & Diluted Shares Outstanding		 78.28M 80.51M 82.50M 84.89M 87.47M 91.20M 90.83M 93.50M 96.59M 100.27M 112.68M

Quarterly Income Statements for Accuray

This table shows Accuray's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 -3.95 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12
Consolidated Net Income / (Loss)		 -3.95 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12
Net Income / (Loss) Continuing Operations		 -3.95 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12
Total Pre-Tax Income 		-3.33 -8.74 -5.90 3.86 -3.33 3.23 -0.84 2.07 -21 -13 -11
Total Operating Income		 -2.15 -3.96 -4.56 6.82 -2.15 4.71 1.05 4.23 -11 -12 -9.09
Total Gross Profit		 34 36 29 38 34 42 32 39 27 24 25
Total Revenue		 102 107 101 134 102 116 113 128 94 102 105
Operating Revenue		 102 107 101 134 102 116 113 128 94 102 105
Total Cost of Revenue		 67 71 72 96 67 74 82 89 67 78 80
Operating Cost of Revenue		 67 71 72 96 67 74 82 89 67 78 80
Total Operating Expenses		 37 40 34 32 37 37 31 35 38 36 34
Selling, General & Admin Expense		 13 13 12 11 13 12 11 12 15 10 11
Marketing Expense		 12 11 10 11 12 11 9.11 11 12 8.85 8.44
Research & Development Expense		 12 15 11 9.53 12 14 11 11 11 11 8.18
Restructuring Charge		 - - - - - 0.00 0.00 - - 6.08 6.54
Total Other Income / (Expense), net		 -1.18 -4.78 -1.34 -2.96 -1.18 -1.48 -1.89 -2.16 -9.89 -1.63 -2.25
Interest Expense		 2.96 2.92 2.88 - 2.96 2.88 2.89 2.75 8.05 7.71 8.45
Interest & Investment Income		 -0.07 -0.43 1.02 0.81 -0.07 1.60 2.30 0.89 0.44 0.47 0.41
Other Income / (Expense), net		 1.85 -1.43 0.52 7.86 1.85 -0.20 -1.29 -0.30 -2.28 5.61 5.79
Income Tax Expense		 0.63 0.88 0.44 0.47 0.63 0.70 0.46 0.95 0.47 0.57 0.47
Basic Earnings per Share		 ($0.04) ($0.10) ($0.06) $0.03 ($0.04) $0.03 ($0.01) - ($0.18) ($0.11) ($0.09)
Weighted Average Basic Shares Outstanding		 100.23M 97.78M 99.20M 98.27M 100.23M 101.41K 102.83K 102.77M 118.95M 120.97M 124.30M
Weighted Average Diluted Shares Outstanding		 100.23M 97.78M 99.20M 98.27M 113.34M 103.75K 103.01M 112.68M - 120.97M 118.96M
Weighted Average Basic & Diluted Shares Outstanding		 100.57M 99.17M 99.24M 100.27M 113.34M 102.83M 103.01M 112.68M - 118.78M 118.96M

Annual Cash Flow Statements for Accuray

This table details how cash moves in and out of Accuray's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Net Change in Cash & Equivalents		 -11 38 -37 8.64 -5.48 22 8.29 -28 1.05 -19 -9.92
Net Cash From Operating Activities		 -14 31 -0.38 18 -30 -1.47 39 -2.40 16 -12 2.86
Net Cash From Continuing Operating Activities		 -14 31 -0.38 18 -30 -1.47 39 -2.40 16 -12 2.86
Net Income / (Loss) Continuing Operations		 -40 -26 -30 -24 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59
Consolidated Net Income / (Loss)		 -40 -26 -30 -24 -16 3.83 -6.31 -5.35 -9.28 -16 -1.59
Depreciation Expense		 19 18 18 9.73 10 7.54 6.39 5.51 4.53 5.91 6.15
Amortization Expense		 2.52 2.53 3.85 1.61 1.53 1.35 1.36 0.82 0.93 0.96 1.44
Non-Cash Adjustments To Reconcile Net Income		 23 23 15 27 19 9.50 29 17 14 11 13
Changes in Operating Assets and Liabilities, net		 -19 13 -7.60 3.89 -44 -24 8.35 -20 5.40 -14 -16
Net Cash From Investing Activities		 3.69 8.26 18 18 -4.31 -3.73 -2.40 -4.72 -13 -3.60 -8.52
Net Cash From Continuing Investing Activities		 3.69 8.26 18 18 -4.31 -3.73 -2.40 -4.72 -13 -3.60 -8.52
Purchase of Property, Plant & Equipment		 -10 -8.07 -5.03 -6.28 -4.31 -3.56 -2.32 -4.72 -13 -3.60 -4.27
Other Investing Activities, net		 - - - - - - - - - 0.00 -4.25
Net Cash From Financing Activities		 5.90 -0.76 -55 -27 28 27 -29 -15 -2.11 -3.95 -4.25
Net Cash From Continuing Financing Activities		 5.90 -0.76 -55 -27 28 27 -29 -15 -2.11 -3.95 -4.25
Repayment of Debt		 - -66 -105 -98 0.00 -0.26 -122 -15 -3.11 -11 -183
Issuance of Debt		 - 65 48 66 25 25 105 0.00 5.00 5.00 177
Issuance of Common Equity		 6.56 3.85 3.79 4.39 3.93 2.45 3.03 3.89 2.20 2.25 1.63
Other Financing Activities, net		 -0.66 -2.83 -1.42 -0.29 0.00 -0.21 -0.34 -4.26 -6.20 -0.12 -0.09
Cash Interest Paid		 7.21 10 9.93 9.19 9.76 12 12 7.46 9.85 11 9.74
Cash Income Taxes Paid		 3.18 1.03 4.46 1.46 2.19 2.81 1.87 1.40 2.15 1.75 3.87

Quarterly Cash Flow Statements for Accuray

This table details how cash moves in and out of Accuray's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -9.26 -4.20 -12 8.24 -11 6.00 14 -20 7.88 -22 -3.71
Net Cash From Operating Activities		 -7.29 -5.09 -8.10 9.88 -7.29 1.80 18 -9.71 12 -16 -5.60
Net Cash From Continuing Operating Activities		 -7.29 -5.09 -8.10 9.88 -7.29 1.80 18 -9.71 12 -16 -5.56
Net Income / (Loss) Continuing Operations		 -3.95 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12
Consolidated Net Income / (Loss)		 -3.95 -9.62 -6.34 3.39 -3.95 2.54 -1.30 1.12 -22 -14 -12
Depreciation Expense		 1.46 1.55 1.60 1.51 1.46 1.51 1.58 1.60 1.68 2.16 2.08
Amortization Expense		 0.25 0.24 0.24 0.24 0.25 0.28 0.27 0.64 1.91 1.62 2.33
Non-Cash Adjustments To Reconcile Net Income		 7.33 1.90 5.24 5.63 7.33 -3.36 6.58 2.54 9.30 -1.54 1.85
Changes in Operating Assets and Liabilities, net		 -12 0.85 -8.83 -0.89 -12 0.84 11 -16 21 -4.46 -0.01
Net Cash From Investing Activities		 -1.12 -1.25 -0.80 -0.47 -1.12 -1.57 -2.43 -3.40 -3.82 -5.60 -1.51
Net Cash From Continuing Investing Activities		 -1.12 -1.25 -0.80 -0.47 -1.12 -1.57 -2.43 -3.40 -3.82 -5.60 -1.51
Purchase of Property, Plant & Equipment		 -1.12 -1.25 -0.80 -0.47 -1.12 -0.87 -0.96 -1.32 -1.90 -3.03 -0.47
Other Investing Activities, net		 0.00 - - - 0.00 -0.70 -1.47 -2.08 -1.92 -2.57 -1.04
Net Cash From Financing Activities		 -2.17 -0.26 -1.50 -0.69 -2.17 5.77 -2.00 -5.85 -0.48 -0.28 4.11
Net Cash From Continuing Financing Activities		 -2.17 -0.26 -1.50 -0.69 -2.17 5.77 -2.00 -5.85 -0.48 -0.28 4.11
Repayment of Debt		 -10 - - -5.08 -10 -10 - -163 -2.00 -5.38 -0.51
Issuance of Debt		 10 - - 5.00 10 17 - 150 2.00 5.00 5.00
Other Financing Activities, net		 -2.00 -1.62 -1.50 -1.50 -2.00 -2.09 -2.00 6.00 -0.48 -0.42 -0.38

Annual Balance Sheets for Accuray

This table presents Accuray's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
Total Assets		 467 469 406 379 438 491 480 473 479 469 470
Total Current Assets		 354 362 309 284 344 357 353 351 338 323 317
Cash & Equivalents		 80 120 72 83 77 108 116 89 89 69 57
Restricted Cash		 3.73 0.89 13 9.83 10 1.00 0.56 0.20 0.52 0.49 0.57
Accounts Receivable		 78 57 73 66 112 91 85 94 75 92 83
Inventories, net		 106 116 105 109 121 134 126 142 145 138 141
Prepaid Expenses		 16 16 19 16 24 21 22 24 28 23 34
Other Current Assets		 6.87 4.88 3.35 1.14 0.15 2.71 3.01 1.46 0.57 0.85 1.76
Plant, Property, & Equipment, net		 32 28 23 24 17 15 12 13 21 25 29
Total Noncurrent Assets		 81 79 74 71 77 118 115 109 120 121 124
Long-Term Investments		 - - - - 0.00 14 16 14 15 9.83 4.61
Goodwill		 58 58 58 58 58 58 58 58 58 58 58
Other Noncurrent Operating Assets		 7.00 13 15 12 17 44 39 36 46 53 62
Total Liabilities & Shareholders' Equity		 467 469 406 379 438 491 480 473 479 469 470
Total Liabilities		 391 409 360 330 388 427 411 420 426 424 389
Total Current Liabilities		 170 210 284 169 192 182 192 209 199 195 193
Short-Term Debt		 - 40 113 - - 0.00 3.79 8.56 5.72 7.76 13
Accounts Payable		 13 15 17 20 30 23 19 31 34 50 34
Accrued Expenses		 19 22 24 22 33 27 27 30 38 29 29
Current Deferred Revenue		 116 114 105 98 99 106 107 101 93 72 95
Current Employee Benefit Liabilities		 22 19 25 29 31 18 27 29 24 17 15
Other Current Liabilities		 - - - - 0.00 8.22 8.17 8.57 4.15 20 7.38
Total Noncurrent Liabilities		 221 199 75 161 196 245 219 211 227 228 196
Long-Term Debt		 200 171 52 131 160 189 170 172 172 164 124
Noncurrent Deferred Revenue		 10 18 14 21 27 24 24 25 27 24 27
Other Noncurrent Operating Liabilities		 11 11 10 8.61 9.65 32 25 14 28 40 46
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 76 60 47 49 50 64 69 53 54 45 81
Total Preferred & Common Equity		 76 60 47 49 50 64 69 53 54 45 81
Total Common Equity		 76 60 47 49 50 64 69 53 54 45 81
Common Stock		 472 481 497 522 535 546 555 543 555 567 602
Retained Earnings		 -395 -421 -450 -474 -486 -482 -488 -493 -502 -518 -519
Accumulated Other Comprehensive Income / (Loss)		 -0.43 -0.96 -0.05 1.09 -0.01 -0.48 2.09 2.41 0.42 -4.22 -1.84

Quarterly Balance Sheets for Accuray

This table presents Accuray's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 12/31/2023 3/31/2024 9/30/2025 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 473 476 463 457 478 484 457 448 448
Total Current Assets		 330 331 314 304 326 333 304 292 293
Cash & Equivalents		 59 73 60 63 63 78 63 41 38
Restricted Cash		 0.49 0.49 0.67 0.57 1.43 1.01 0.57 0.58 0.47
Accounts Receivable		 92 77 73 54 87 78 54 61 65
Inventories, net		 155 155 160 156 149 146 156 151 157
Prepaid Expenses		 21 25 19 29 25 29 29 37 33
Other Current Assets		 1.72 0.28 1.02 0.43 0.33 0.78 0.43 1.63 0.02
Plant, Property, & Equipment, net		 25 26 25 29 27 27 29 29 29
Total Noncurrent Assets		 118 119 123 124 126 124 124 126 125
Long-Term Investments		 6.05 15 14 4.01 13 9.28 4.01 5.80 6.32
Goodwill		 58 58 58 58 58 58 58 58 58
Other Noncurrent Operating Assets		 53 46 51 56 54 55 62 63 61
Total Liabilities & Shareholders' Equity		 473 476 463 457 478 484 457 448 448
Total Liabilities		 428 429 421 395 430 435 395 395 406
Total Current Liabilities		 202 209 198 195 201 203 195 199 206
Short-Term Debt		 7.77 6.74 7.25 13 7.56 7.57 13 11 11
Accounts Payable		 50 39 44 42 54 46 42 44 53
Accrued Expenses		 25 36 31 26 28 35 26 31 26
Current Deferred Revenue		 94 100 89 92 85 94 92 79 90
Current Employee Benefit Liabilities		 18 21 22 14 19 13 14 15 17
Other Current Liabilities		 6.78 5.71 5.28 7.46 7.52 7.23 7.46 20 8.23
Total Noncurrent Liabilities		 226 219 223 200 229 231 200 195 200
Long-Term Debt		 162 168 166 127 168 166 127 125 134
Noncurrent Deferred Revenue		 24 25 24 26 25 26 26 28 27
Other Noncurrent Operating Liabilities		 39 27 33 47 36 39 47 43 39
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 45 48 41 62 48 50 62 53 42
Total Preferred & Common Equity		 45 48 41 62 48 50 62 53 42
Total Common Equity		 45 48 41 62 48 50 62 53 42
Common Stock		 569 561 564 605 572 575 605 610 611
Retained Earnings		 -522 -515 -521 -541 -519 -520 -541 -555 -567
Accumulated Other Comprehensive Income / (Loss)		 -2.48 1.06 -1.91 -1.98 -5.40 -5.16 -1.98 -1.39 -2.67

Annual Metrics And Ratios for Accuray

This table displays calculated financial ratios and metrics derived from Accuray's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 6/30/2015 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025
DEI Shares Outstanding		 78,986,768.00 80,924,480.00 83,000,966.00 85,638,116.00 88,024,096.00 90,516,626.00 93,260,654.00 92,802,213.00 95,751,773.00 - 103,013,384.00
DEI Adjusted Shares Outstanding		 78,986,768.00 80,924,480.00 83,000,966.00 85,638,116.00 88,024,096.00 90,516,626.00 93,260,654.00 92,802,213.00 95,751,773.00 - 103,013,384.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.51 -0.32 -0.36 3.50 -0.19 0.04 -0.07 -0.06 -0.10 - -0.02
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 2.81% 5.00% -3.86% 111.21% -48.29% -8.56% 3.49% 8.48% 4.12% -0.24% 2.68%
EBITDA Growth		 -79.19% 85.15% -183.65% -75.67% 80.09% 733.46% -84.29% 427.92% -44.95% -28.24% 220.93%
EBIT Growth		 -16.78% 38.69% -23.19% 19.34% 37.69% 140.71% -193.01% 208.38% -78.39% -259.91% 488.35%
NOPAT Growth		 -5.65% 74.58% -101.58% 61.35% 115.35% 1,966.53% 84.56% -63.36% -70.77% -78.84% -3,217.38%
Net Income Growth		 -13.43% 36.57% -15.98% 19.20% 31.25% 123.29% -264.91% 15.27% -73.56% -67.51% 89.77%
EPS Growth		 -8.51% 37.25% -12.50% 22.22% 32.14% 121.05% -275.00% 14.29% -66.67% -60.00% 0.00%
Operating Cash Flow Growth		 -4,264.45% 314.62% -101.23% 4,923.95% -261.70% 95.04% 2,721.65% -106.23% 747.46% -176.61% 124.03%
Free Cash Flow Firm Growth		 -310.54% 215.81% -134.28% 261.33% -366.29% 102.48% 4,064.02% -142.64% 143.33% -280.46% -107.00%
Invested Capital Growth		 5.86% -21.23% 1.25% -15.48% 41.03% 6.22% -15.96% 19.47% -3.87% 9.96% 12.09%
Revenue Q/Q Growth		 -0.07% -1.67% 4.67% 100.84% -54.60% -22.08% 106.48% 2.39% -0.60% 3.72% 0.00%
EBITDA Q/Q Growth		 18.10% -310.33% 37.06% -5.37% 55.33% -8.99% -83.32% 225.01% 96.12% 134.84% 0.00%
EBIT Q/Q Growth		 9.23% -7.61% 7.37% 13.20% 5.41% 21.09% -197.10% 135.94% 158.32% 89.98% 0.00%
NOPAT Q/Q Growth		 14.26% -43.70% 37.02% 6.82% 39.47% 56.05% -9.99% 44.24% -74.87% 107.44% 0.00%
Net Income Q/Q Growth		 9.48% -6.72% 6.19% 15.28% -2.84% 48.39% -236.34% 69.28% -61.25% 27.66% 0.00%
EPS Q/Q Growth		 12.07% -10.34% 5.26% 17.65% -5.56% 100.00% -240.00% 68.42% -66.67% 27.27% 0.00%
Operating Cash Flow Q/Q Growth		 -10.07% 232.96% 89.70% 34.95% -173.42% 86.89% -24.69% -128.44% 671.55% 7.76% -87.26%
Free Cash Flow Firm Q/Q Growth		 -5.11% 1,514.15% -16.87% 45.45% -54.24% 109.38% -22.49% -749.34% 257.95% 9.96% 0.00%
Invested Capital Q/Q Growth		 2.29% -16.87% -12.99% -18.16% -5.24% -9.67% -4.44% 8.64% -4.28% -1.31% 0.00%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 38.28% 39.80% 36.86% 39.93% 38.84% 39.10% 40.25% 37.21% 34.40% 32.01% 32.05%
EBITDA Margin		 -4.15% -0.59% -1.73% -1.44% -0.56% 3.85% 0.58% 2.84% 1.50% 1.08% 3.38%
Operating Margin		 -5.05% -1.22% -2.56% -0.47% 0.14% 3.27% 5.61% 1.90% 0.53% 0.11% 1.71%
EBIT Margin		 -9.95% -5.81% -7.44% -2.84% -3.43% 1.52% -1.37% 1.37% 0.28% -0.46% 1.72%
Profit (Net Income) Margin		 -10.59% -6.40% -7.71% -2.95% -3.92% 1.00% -1.59% -1.24% -2.07% -3.48% -0.35%
Tax Burden Percent		 106.40% 110.08% 103.64% 103.81% 114.54% 67.26% 138.43% 267.08% 136.71% 131.51% -140.30%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 97.45% 83.94% -34.01% -533.65% 581.12% 14.36%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 32.74% 0.00% 0.00% 0.00% 0.00% 240.30%
Return on Invested Capital (ROIC)		 -10.79% -2.99% -6.79% -2.83% 0.39% 6.73% 13.10% 4.79% 1.31% 0.27% -7.50%
ROIC Less NNEP Spread (ROIC-NNEP)		 -82.92% -50.44% -53.85% -48.52% -30.44% 0.01% -28.52% -14.25% -13.54% -19.25% 3.76%
Return on Net Nonoperating Assets (RNNOA)		 -35.34% -34.68% -48.92% -47.40% -33.75% 0.01% -22.63% -13.55% -18.68% -31.76% 4.98%
Return on Equity (ROE)		 -46.13% -37.66% -55.71% -50.23% -33.36% 6.74% -9.53% -8.76% -17.37% -31.49% -2.52%
Cash Return on Invested Capital (CROIC)		 -16.49% 20.77% -8.03% 13.95% -33.66% 0.69% 30.44% -12.95% 5.26% -9.22% -18.90%
Operating Return on Assets (OROA)		 -7.86% -4.95% -6.52% -5.86% -3.51% 1.26% -1.12% 1.24% 0.27% -0.43% 1.68%
Return on Assets (ROA)		 -8.36% -5.45% -6.76% -6.09% -4.02% 0.82% -1.30% -1.12% -1.95% -3.28% -0.34%
Return on Common Equity (ROCE)		 -46.13% -37.66% -55.71% -50.23% -33.36% 6.74% -9.53% -8.76% -17.37% -31.49% -2.52%
Return on Equity Simple (ROE_SIMPLE)		 -53.06% -42.75% -63.57% -49.14% -32.95% 6.01% -9.17% -10.05% -17.29% -34.48% 0.00%
Net Operating Profit after Tax (NOPAT)		 -13 -3.41 -6.88 -2.66 0.41 8.43 16 5.70 1.67 0.35 -11
NOPAT Margin		 -3.53% -0.86% -1.79% -0.33% 0.10% 2.20% 3.93% 1.33% 0.37% 0.08% -2.40%
Net Nonoperating Expense Percent (NNEP)		 72.13% 47.46% 47.07% 45.69% 30.84% 6.72% 41.62% 19.04% 14.86% 19.52% -11.25%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - - - -5.05%
Cost of Revenue to Revenue		 61.72% 60.20% 63.14% 60.07% 61.16% 60.90% 59.75% 62.79% 65.60% 67.99% 67.95%
SG&A Expenses to Revenue		 12.21% 12.57% 11.41% 5.94% 11.84% 10.48% 10.53% 10.33% 10.78% 11.21% 10.44%
R&D to Revenue		 14.68% 14.21% 13.02% 7.07% 13.49% 13.00% 13.31% 13.43% 12.76% 11.14% 10.46%
Operating Expenses to Revenue		 43.33% 41.02% 39.43% 0.47% 38.70% 35.82% 34.64% 35.31% 33.86% 31.89% 30.34%
Earnings before Interest and Taxes (EBIT)		 -38 -23 -29 -23 -14 5.84 -5.43 5.89 1.27 -2.03 7.90
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -16 -2.34 -6.65 -12 -2.33 15 2.31 12 6.73 4.83 15
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 7.03 7.04 8.47 7.22 6.83 2.89 6.12 3.42 6.91 4.01 1.74
Price to Tangible Book Value (P/TBV)		 246.24 0.00 0.00 0.00 0.00 34.97 40.36 0.00 0.00 0.00 6.04
Price to Revenue (P/Rev)		 1.40 1.05 1.03 0.43 0.81 0.48 1.06 0.42 0.83 0.40 0.31
Price to Earnings (P/E)		 0.00 0.00 0.00 1.17 0.00 48.01 0.00 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 85.30% 0.00% 2.08% 0.00% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 4.57 4.59 4.41 4.52 3.40 1.94 4.26 2.00 3.55 2.00 1.39
Enterprise Value to Revenue (EV/Rev)		 1.54 1.16 1.17 0.48 0.99 0.65 1.17 0.60 0.99 0.61 0.47
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 17.01 199.86 21.25 65.84 56.76 13.88
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 42.91 0.00 44.09 348.10 0.00 27.22
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 1,013.19 29.71 29.71 45.51 265.56 776.36 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 14.96 0.00 21.24 0.00 0.00 12.01 0.00 28.50 0.00 75.19
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 19.49 0.00 29.66 0.00 288.48 12.79 0.00 66.27 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 2.63 3.53 3.54 2.70 3.21 2.97 2.52 3.39 3.30 3.82 1.68
Long-Term Debt to Equity		 2.63 2.86 1.11 2.70 3.21 2.97 2.47 3.23 3.20 3.65 1.53
Financial Leverage		 0.43 0.69 0.91 0.98 1.11 1.21 0.79 0.95 1.38 1.65 1.32
Leverage Ratio		 5.52 6.91 8.24 8.25 8.29 8.19 7.33 7.81 8.91 9.60 7.44
Compound Leverage Factor		 5.52 6.91 8.24 8.25 8.29 7.98 6.15 -2.66 -47.55 55.78 1.07
Debt to Total Capital		 72.49% 77.91% 77.96% 72.94% 76.22% 74.84% 71.63% 77.24% 76.77% 79.25% 62.71%
Short-Term Debt to Total Capital		 0.00% 14.77% 53.54% 0.00% 0.00% 0.00% 1.56% 3.66% 2.48% 3.57% 5.85%
Long-Term Debt to Total Capital		 72.49% 63.14% 24.42% 72.94% 76.22% 74.84% 70.07% 73.57% 74.29% 75.68% 56.86%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 27.51% 22.09% 22.04% 27.06% 23.78% 25.16% 28.37% 22.76% 23.23% 20.75% 37.29%
Debt to EBITDA		 -12.66 -89.80 -24.76 -11.23 -68.75 12.85 75.11 14.77 26.36 35.67 8.81
Net Debt to EBITDA		 -3.30 -18.14 -8.39 -3.27 -31.32 4.54 17.69 6.36 10.74 19.33 4.77
Long-Term Debt to EBITDA		 -12.66 -72.78 -7.76 -11.23 -68.75 12.85 73.47 14.07 25.51 34.07 7.99
Debt to NOPAT		 -14.88 -61.68 -23.93 -49.32 391.68 22.45 11.17 31.64 106.32 487.97 -12.41
Net Debt to NOPAT		 -3.88 -12.46 -8.11 -14.36 178.46 7.92 2.63 13.61 43.32 264.38 -6.72
Long-Term Debt to NOPAT		 -14.88 -49.99 -7.50 -49.32 391.68 22.45 10.92 30.14 102.89 465.99 -11.26
Altman Z-Score		 0.65 0.43 -0.11 1.19 0.24 0.13 0.38 0.11 0.35 -0.02 0.02
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 2.09 1.72 1.09 1.68 1.79 1.96 1.83 1.68 1.70 1.66 1.65
Quick Ratio		 1.30 1.06 0.59 0.88 0.98 1.09 1.05 0.88 0.83 0.82 0.73
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -20 24 -8.14 13 -35 0.87 36 -15 6.68 -12 -28
Operating Cash Flow to CapEx		 -137.95% 383.40% -7.55% 292.08% -687.57% -41.29% 1,660.00% -50.88% 123.19% -330.57% 66.95%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.90 0.63 -1.04 -2.42
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.30 1.46 -1.02 0.25
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.88 0.28 -1.33 -0.12
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.79 0.85 0.88 2.06 1.03 0.82 0.82 0.90 0.94 0.94 0.98
Accounts Receivable Turnover		 5.07 5.93 5.92 11.67 4.71 3.78 4.50 4.78 5.29 5.36 5.23
Inventory Turnover		 2.42 2.16 2.19 4.55 2.23 1.83 1.82 2.01 2.04 2.14 2.23
Fixed Asset Turnover		 11.47 13.36 15.05 34.64 20.52 23.59 28.63 34.37 26.63 19.54 17.16
Accounts Payable Turnover		 16.31 16.95 14.80 26.16 10.40 8.85 11.12 10.63 9.02 7.25 7.41
Days Sales Outstanding (DSO)		 72.02 61.57 61.69 31.28 77.52 96.50 81.03 76.33 68.99 68.16 69.73
Days Inventory Outstanding (DIO)		 150.97 168.86 166.64 80.14 163.43 199.71 200.63 181.30 178.62 170.39 163.64
Days Payable Outstanding (DPO)		 22.37 21.53 24.66 13.95 35.10 41.23 32.83 34.35 40.44 50.34 49.24
Cash Conversion Cycle (CCC)		 200.62 208.89 203.67 97.47 205.85 254.98 248.83 223.28 207.17 188.20 184.13
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 128 101 102 86 122 129 109 130 125 137 155
Invested Capital Turnover		 3.06 3.49 3.78 8.61 4.03 3.06 3.34 3.61 3.52 3.41 3.13
Increase / (Decrease) in Invested Capital		 7.08 -27 1.26 -16 35 7.57 -21 21 -5.01 12 17
Enterprise Value (EV)		 584 463 450 389 413 251 462 260 443 274 215
Market Capitalization		 532 420 394 351 341 184 422 182 371 181 141
Book Value per Share		 $0.96 $0.74 $0.56 $0.57 $0.57 $0.70 $0.74 $0.57 $0.56 $0.45 $0.79
Tangible Book Value per Share		 $0.03 ($0.07) ($0.15) ($0.12) ($0.10) $0.06 $0.11 ($0.05) ($0.04) ($0.13) $0.23
Total Capital		 275 270 211 180 210 253 243 234 231 217 218
Total Debt		 200 210 165 131 160 189 174 180 177 172 137
Total Long-Term Debt		 200 171 52 131 160 189 170 172 172 164 124
Net Debt		 52 43 56 38 73 67 41 78 72 93 74
Capital Expenditures (CapEx)		 10 8.07 5.03 6.28 4.31 3.56 2.32 4.72 13 3.60 4.27
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 37 23 29 22 65 67 47 62 55 67 80
Debt-free Net Working Capital (DFNWC)		 184 191 138 115 152 175 164 151 145 136 138
Net Working Capital (NWC)		 184 151 25 115 152 175 160 142 139 128 125
Net Nonoperating Expense (NNE)		 27 22 23 21 17 4.61 22 11 11 16 -9.41
Net Nonoperating Obligations (NNO)		 52 41 55 38 72 65 40 76 71 92 74
Total Depreciation and Amortization (D&A)		 22 21 22 11 12 8.89 7.75 6.33 5.45 6.86 7.59
Debt-free, Cash-free Net Working Capital to Revenue		 9.70% 5.88% 7.49% 2.69% 15.49% 17.40% 11.93% 14.34% 12.33% 14.93% 17.37%
Debt-free Net Working Capital to Revenue		 48.56% 47.99% 35.87% 14.17% 36.27% 45.76% 41.44% 35.03% 32.42% 30.39% 30.01%
Net Working Capital to Revenue		 48.56% 37.98% 6.39% 14.17% 36.27% 45.76% 40.48% 33.04% 31.14% 28.66% 27.24%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.51) ($0.32) ($0.36) ($0.28) ($0.19) $0.04 ($0.07) ($0.06) ($0.10) ($0.16) ($0.02)
Adjusted Weighted Average Basic Shares Outstanding		 79.75M 81.57M 83.75M 86.49M 88.78M 89.87M 92.03M 92.10M 94.88M 98.27M 102.77M
Adjusted Diluted Earnings per Share		 ($0.51) ($0.32) ($0.36) ($0.28) ($0.19) $0.04 ($0.07) ($0.06) ($0.10) ($0.16) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 79.75M 81.57M 83.75M 86.49M 88.78M 90.62M 92.03M 92.10M 94.88M 98.27M 112.68M
Adjusted Basic & Diluted Earnings per Share		 ($0.51) ($0.32) ($0.36) ($0.28) ($0.19) $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 78.28M 80.51M 82.50M 84.89M 87.47M 91.20M 90.83M 93.50M 96.59M 100.27M 112.68M
Normalized Net Operating Profit after Tax (NOPAT)		 -13 -3.41 -6.88 -2.66 0.41 8.43 16 5.70 1.67 0.35 5.49
Normalized NOPAT Margin		 -3.53% -0.86% -1.79% -0.33% 0.10% 2.20% 3.93% 1.33% 0.37% 0.08% 1.20%
Pre Tax Income Margin		 -9.95% -5.81% -7.44% -2.84% -3.43% 1.49% -1.15% -0.47% -1.52% -2.65% 0.25%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.72 0.12 -0.18 0.69
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.70 0.16 0.03 -0.96
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.14 -1.07 -0.48 0.32
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.12 -1.03 -0.28 -1.33
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -223.10% 0.00% 0.00% 0.00% 0.00%

Quarterly Metrics And Ratios for Accuray

This table displays calculated financial ratios and metrics derived from Accuray's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2024 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 100,267,900.00 97,072,183.00 99,168,765.00 - 100,267,900.00 - 102,830,522.00 103,013,384.00 112,677,147.00 113,341,132.00 356,347,890.00
DEI Adjusted Shares Outstanding		 100,267,900.00 97,072,183.00 99,168,765.00 - 100,267,900.00 - 102,830,522.00 103,013,384.00 112,677,147.00 113,341,132.00 356,347,890.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.04 -0.10 -0.06 - -0.04 - -0.01 0.01 -0.19 -0.12 -0.03
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 5.24% -6.55% -14.34% 13.52% 0.00% 8.33% 11.98% -6.65% -7.49% -11.99% -7.42%
EBITDA Growth		 142.33% -388.19% -602.51% 96.00% 0.00% 224.92% 172.60% -34.66% -807.13% -134.56% -30.91%
EBIT Growth		 93.63% -4,180.95% -345.70% 108.29% 0.00% 183.63% 93.88% -48.87% -4,401.32% -232.10% -1,235.63%
NOPAT Growth		 1.51% -246.54% -358.04% 1,970.82% 0.00% 233.16% 122.95% -71.11% -426.43% -319.12% -967.91%
Net Income Growth		 27.44% -413.39% -1,158.76% 232.51% 0.00% 126.37% 79.55% -74.31% -448.25% -642.77% -810.18%
EPS Growth		 33.33% -400.00% -700.00% 200.00% 0.00% 120.00% 0.00% 0.00% 0.00% -650.00% 0.00%
Operating Cash Flow Growth		 -15,956.52% 71.73% -132.90% 11.27% 0.00% 0.00% 322.92% -198.24% 266.99% -987.62% -131.02%
Free Cash Flow Firm Growth		 -218.30% 125.51% -23.02% -236.88% 112.47% -158.26% 148.37% -148.83% -174.56% 43.83% -354.02%
Invested Capital Growth		 0.00% -11.11% 6.65% 9.96% -13.61% 8.84% -3.60% 12.09% 4.69% -2.44% 6.12%
Revenue Q/Q Growth		 -14.16% 5.61% -5.69% 32.79% -25.68% 0.00% -2.52% 12.63% 0.00% 8.83% 2.55%
EBITDA Q/Q Growth		 -83.10% -355.01% 39.05% 422.97% -85.02% 0.00% -74.63% 286.42% 0.00% 78.26% 150.71%
EBIT Q/Q Growth		 -104.29% -1,686.09% 25.14% 311.96% -103.92% 0.00% -105.48% 1,693.93% 0.00% 56.16% 44.64%
NOPAT Q/Q Growth		 -370.24% -84.46% -15.09% 287.41% -118.93% 0.00% -80.16% 213.26% 0.00% -2.24% 21.43%
Net Income Q/Q Growth		 -54.69% -143.32% 34.08% 153.41% -190.44% 0.00% -151.12% 186.58% 0.00% 36.48% 14.27%
EPS Q/Q Growth		 -33.33% -150.00% 40.00% 150.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Cash Flow Q/Q Growth		 -182.13% 30.18% -59.08% 221.97% -173.81% 0.00% 902.83% -153.75% 225.46% -231.25% 64.96%
Free Cash Flow Firm Q/Q Growth		 -3,291.03% 109.28% -185.19% 45.76% 518.64% 0.00% 170.73% -351.87% 0.00% 67.34% -219.87%
Invested Capital Q/Q Growth		 19.00% -10.05% 4.09% -1.31% -6.51% 0.00% -7.81% 15.88% 0.00% 5.61% 0.28%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 33.94% 33.48% 28.75% 28.63% 33.94% 36.06% 27.93% 30.56% 28.26% 23.54% 24.13%
EBITDA Margin		 1.39% -3.37% -2.18% 12.23% 1.39% 3.88% 1.41% 4.84% -10.66% -2.13% 1.05%
Operating Margin		 -2.12% -3.70% -4.51% 5.08% -2.12% 4.05% 0.92% 3.32% -12.04% -11.31% -8.67%
EBIT Margin		 -0.30% -5.03% -3.99% 10.93% -0.30% 3.88% -0.22% 3.09% -14.47% -5.83% -3.15%
Profit (Net Income) Margin		 -3.89% -8.97% -6.27% 2.52% -3.89% 2.18% -1.15% 0.88% -23.08% -13.47% -11.26%
Tax Burden Percent		 118.77% 110.04% 107.53% 87.79% 118.77% 78.50% 154.40% 54.23% 102.22% 104.34% 104.13%
Interest Burden Percent		 1,102.32% 162.09% 146.06% 26.30% 1,102.32% 71.65% 340.08% 52.60% 156.00% 221.46% 343.65%
Effective Tax Rate		 0.00% 0.00% 0.00% 12.21% 0.00% 21.50% 0.00% 45.78% 0.00% 0.00% 0.00%
Return on Invested Capital (ROIC)		 -9.04% -8.17% -10.11% 15.21% -4.79% 0.00% 2.22% 5.63% -28.99% -24.13% -18.85%
ROIC Less NNEP Spread (ROIC-NNEP)		 -13.80% -15.61% -13.74% 12.02% -7.68% 0.00% -0.01% 4.22% -48.86% -30.25% -24.75%
Return on Net Nonoperating Assets (RNNOA)		 -31.45% -28.90% -24.85% 19.83% -12.14% 0.00% -0.02% 5.59% -54.69% -55.38% -50.04%
Return on Equity (ROE)		 -40.49% -37.07% -34.96% 35.05% -16.93% 0.00% 2.20% 11.22% -83.68% -79.51% -68.89%
Cash Return on Invested Capital (CROIC)		 -197.72% 11.82% -9.96% -9.22% 14.86% 0.00% 7.11% -18.90% -5.29% -6.12% -20.01%
Operating Return on Assets (OROA)		 -0.28% -4.76% -3.66% 10.29% -0.29% 0.00% -0.22% 3.01% -14.28% -5.50% -2.89%
Return on Assets (ROA)		 -3.73% -8.50% -5.76% 2.38% -3.74% 0.00% -1.13% 0.86% -22.78% -12.71% -10.36%
Return on Common Equity (ROCE)		 -40.49% -37.07% -34.96% 35.05% -16.93% 0.00% 2.20% 11.22% -83.68% -79.51% -68.89%
Return on Equity Simple (ROE_SIMPLE)		 0.00% -30.53% -52.31% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -1.50 -2.77 -3.19 5.98 -1.50 3.69 0.73 2.30 -7.92 -8.10 -6.36
NOPAT Margin		 -1.48% -2.59% -3.16% 4.46% -1.48% 3.18% 0.65% 1.80% -8.43% -7.92% -6.07%
Net Nonoperating Expense Percent (NNEP)		 4.75% 7.44% 3.64% 3.19% 2.89% 1.27% 2.23% 1.40% 19.87% 6.12% 5.90%
Return On Investment Capital (ROIC_SIMPLE)		 -0.70% -1.25% -1.49% - -0.74% 1.65% 0.33% 1.05% -3.92% -4.28% -3.40%
Cost of Revenue to Revenue		 66.06% 66.52% 71.25% 71.37% 66.06% 63.94% 72.07% 69.44% 71.74% 76.46% 75.87%
SG&A Expenses to Revenue		 12.62% 12.33% 12.27% 8.50% 12.62% 10.70% 9.50% 9.30% 15.46% 9.84% 10.71%
R&D to Revenue		 11.93% 14.25% 10.79% 7.10% 11.93% 11.74% 9.46% 8.99% 12.10% 10.42% 7.80%
Operating Expenses to Revenue		 36.06% 37.18% 33.26% 23.56% 36.06% 32.01% 27.00% 27.24% 40.30% 34.86% 32.79%
Earnings before Interest and Taxes (EBIT)		 -0.30 -5.39 -4.04 15 -0.30 4.51 -0.25 3.94 -14 -5.96 -3.30
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 1.42 -3.61 -2.20 16 1.42 4.51 1.60 6.18 -10 -2.18 1.10
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.99 5.76 5.96 4.01 2.92 4.16 3.71 1.74 3.04 1.75 1.11
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 44.60 0.00 0.00 6.04 46.50 0.00 0.00
Price to Revenue (P/Rev)		 0.40 0.61 0.57 0.40 0.40 0.00 0.39 0.31 0.42 0.21 0.11
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 111.02 0.00 0.00 0.00 0.00
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.90% 0.00% 0.00% 0.00% 0.00%
Enterprise Value to Invested Capital (EV/IC)		 1.92 2.71 2.48 2.00 1.97 2.05 2.02 1.39 1.94 1.28 1.03
Enterprise Value to Revenue (EV/Rev)		 0.63 0.81 0.80 0.61 0.57 0.00 0.58 0.47 0.58 0.42 0.34
Enterprise Value to EBITDA (EV/EBITDA)		 24.81 44.39 62.38 56.76 52.37 0.00 14.37 13.88 64.16 0.00 0.00
Enterprise Value to EBIT (EV/EBIT)		 49.91 164.56 0.00 0.00 0.00 0.00 23.13 27.22 0.00 0.00 0.00
Enterprise Value to NOPAT (EV/NOPAT)		 168.58 4,784.33 0.00 776.36 716.34 0.00 57.36 0.00 0.00 0.00 0.00
Enterprise Value to Operating Cash Flow (EV/OCF)		 34.76 18.25 0.00 0.00 0.00 0.00 12.01 75.19 11.66 39.95 0.00
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 21.59 0.00 0.00 12.30 0.00 27.81 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 3.76 3.67 4.22 3.82 2.27 3.66 3.50 1.68 2.27 2.54 3.48
Long-Term Debt to Equity		 3.59 3.53 4.05 3.65 2.06 3.51 3.35 1.53 2.06 2.34 3.21
Financial Leverage		 2.28 1.85 1.81 1.65 1.58 1.92 2.01 1.32 1.12 1.83 2.02
Leverage Ratio		 10.46 9.51 9.80 9.60 8.68 9.99 10.44 7.44 7.38 9.14 10.21
Compound Leverage Factor		 115.31 15.41 14.31 2.52 95.72 7.16 35.52 3.91 11.52 20.25 35.08
Debt to Total Capital		 79.01% 78.57% 80.85% 79.25% 69.38% 78.56% 77.80% 62.71% 69.38% 71.78% 77.68%
Short-Term Debt to Total Capital		 3.61% 3.03% 3.38% 3.57% 6.36% 3.38% 3.39% 5.85% 6.36% 5.87% 5.97%
Long-Term Debt to Total Capital		 75.41% 75.54% 77.48% 75.68% 63.02% 75.18% 74.41% 56.86% 63.02% 65.91% 71.71%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 20.99% 21.43% 19.15% 20.75% 30.62% 21.44% 22.20% 37.29% 30.62% 28.22% 22.32%
Debt to EBITDA		 14.82 21.45 31.49 35.67 29.04 0.00 9.26 8.81 34.53 -30.76 -29.56
Net Debt to EBITDA		 9.10 10.67 17.93 19.33 14.97 0.00 4.57 4.77 17.80 -19.97 -20.43
Long-Term Debt to EBITDA		 14.15 20.62 30.17 34.07 26.38 0.00 8.86 7.99 31.37 -28.25 -27.29
Debt to NOPAT		 100.70 2,311.61 -36.61 487.97 397.30 0.00 36.96 -12.41 -151.13 -11.03 -7.48
Net Debt to NOPAT		 61.82 1,150.54 -20.84 264.38 204.77 0.00 18.22 -6.72 -77.89 -7.16 -5.17
Long-Term Debt to NOPAT		 96.11 2,222.49 -35.08 465.99 360.87 0.00 35.35 -11.26 -137.27 -10.13 -6.90
Altman Z-Score		 -0.01 0.08 -0.03 0.09 -0.12 0.00 0.04 -0.01 -0.20 -0.41 -0.54
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.63 1.58 1.58 1.66 1.56 1.62 1.64 1.65 1.56 1.47 1.42
Quick Ratio		 0.75 0.72 0.67 0.82 0.60 0.74 0.77 0.73 0.60 0.51 0.50
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -150 14 -12 -6.43 19 -8.10 5.73 -14 -14 -4.55 -15
Operating Cash Flow to CapEx		 -651.25% -407.77% -1,019.12% 2,125.16% -651.25% 0.00% 1,885.28% -735.45% 639.71% -528.46% -1,189.38%
Free Cash Flow to Firm to Interest Expense		 -50.69 4.76 -4.11 0.00 6.32 -2.81 1.98 -5.25 -1.73 -0.59 -1.72
Operating Cash Flow to Interest Expense		 -2.47 -1.74 -2.81 0.00 -2.47 0.00 6.25 -3.53 1.51 -2.07 -0.66
Operating Cash Flow Less CapEx to Interest Expense		 -2.85 -2.17 -3.09 0.00 -2.85 0.00 5.92 -4.01 1.28 -2.47 -0.72
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.96 0.95 0.92 0.94 0.96 0.00 0.99 0.98 0.99 0.94 0.92
Accounts Receivable Turnover		 4.93 5.37 5.72 5.36 6.11 0.00 6.18 5.23 8.29 5.90 6.00
Inventory Turnover		 1.93 1.90 1.86 2.14 1.96 0.00 2.07 2.23 2.01 2.11 2.07
Fixed Asset Turnover		 17.86 24.14 23.20 19.54 16.43 0.00 17.82 17.16 15.54 15.57 15.28
Accounts Payable Turnover		 6.00 8.10 7.89 7.25 6.59 0.00 6.97 7.41 7.36 6.48 6.33
Days Sales Outstanding (DSO)		 74.01 67.94 63.79 68.16 59.74 0.00 59.07 69.73 44.02 61.91 60.79
Days Inventory Outstanding (DIO)		 189.18 191.88 196.26 170.39 186.56 0.00 176.66 163.64 182.00 173.28 176.33
Days Payable Outstanding (DPO)		 60.84 45.08 46.24 50.34 55.42 0.00 52.39 49.24 49.63 56.36 57.67
Cash Conversion Cycle (CCC)		 202.36 214.74 213.81 188.20 190.87 0.00 183.34 184.13 176.40 178.83 179.45
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 148 133 139 137 128 145 134 155 134 142 142
Invested Capital Turnover		 6.11 3.16 3.20 3.41 3.23 0.00 3.43 3.13 3.44 3.05 3.11
Increase / (Decrease) in Invested Capital		 148 -17 8.65 12 -20 12 -5.00 17 6.01 -3.55 8.19
Enterprise Value (EV)		 285 362 344 274 253 298 270 215 260 182 146
Market Capitalization		 180 275 245 181 180 199 184 141 188 93 46
Book Value per Share		 $0.45 $0.49 $0.41 $0.45 $0.62 $0.48 $0.48 $0.79 $0.55 $0.47 $0.35
Tangible Book Value per Share		 ($0.13) ($0.11) ($0.17) ($0.13) $0.04 ($0.10) ($0.08) $0.23 $0.04 ($0.04) ($0.14)
Total Capital		 215 222 215 217 202 223 223 218 202 189 187
Total Debt		 170 175 173 172 140 176 174 137 140 136 145
Total Long-Term Debt		 162 168 166 164 127 168 166 124 127 125 134
Net Debt		 105 87 99 93 72 99 86 74 72 88 100
Capital Expenditures (CapEx)		 1.12 1.25 0.80 0.47 1.12 0.00 0.96 1.32 1.90 3.03 0.47
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 76 55 62 67 58 68 59 80 58 62 60
Debt-free Net Working Capital (DFNWC)		 136 129 123 136 122 132 138 138 122 104 99
Net Working Capital (NWC)		 128 122 116 128 109 124 130 125 109 93 87
Net Nonoperating Expense (NNE)		 2.45 6.85 3.15 2.60 2.45 1.16 2.03 1.17 14 5.67 5.44
Net Nonoperating Obligations (NNO)		 103 86 98 92 66 97 84 74 72 88 100
Total Depreciation and Amortization (D&A)		 1.72 1.78 1.84 1.75 1.72 0.00 1.85 2.24 3.58 3.78 4.40
Debt-free, Cash-free Net Working Capital to Revenue		 16.75% 12.37% 14.32% 14.93% 12.97% 0.00% 12.57% 17.37% 12.85% 14.23% 14.00%
Debt-free Net Working Capital to Revenue		 29.94% 28.74% 28.51% 30.39% 27.29% 0.00% 29.43% 30.01% 27.02% 23.81% 22.99%
Net Working Capital to Revenue		 28.22% 27.23% 26.83% 28.66% 24.41% 0.00% 27.81% 27.24% 24.17% 21.27% 20.39%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 ($0.10) ($0.06) $0.03 ($0.18) $0.03 ($0.01) $0.00 ($0.18) ($0.11) ($0.09)
Adjusted Weighted Average Basic Shares Outstanding		 0.00 97.78M 99.20M 98.27M 118.95M 101.41M 102.83M 102.77M 118.95M 120.97M 124.30M
Adjusted Diluted Earnings per Share		 $0.00 ($0.10) ($0.06) $0.03 ($0.18) $0.02 ($0.01) $0.00 $0.00 ($0.11) $0.00
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 97.78M 99.20M 98.27M 118.95M 103.75M 102.83M 112.68M 0.00 120.97M 118.96M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 99.17M 99.24M 100.27M 113.34M 102.83M 103.01M 112.68M 0.00 118.78M 118.96M
Normalized Net Operating Profit after Tax (NOPAT)		 -1.50 -2.77 -3.19 5.98 -1.50 3.69 0.73 2.30 -7.92 -3.84 -1.78
Normalized NOPAT Margin		 -1.48% -2.59% -3.16% 4.46% -1.48% 3.18% 0.65% 1.80% -8.43% -3.76% -1.70%
Pre Tax Income Margin		 -3.28% -8.15% -5.83% 2.87% -3.28% 2.78% -0.74% 1.62% -22.57% -12.91% -10.81%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -0.10 -1.85 -1.40 0.00 -0.10 1.56 -0.09 1.43 -1.69 -0.77 -0.39
NOPAT to Interest Expense		 -0.51 -0.95 -1.11 0.00 -0.51 1.28 0.25 0.83 -0.98 -1.05 -0.75
EBIT Less CapEx to Interest Expense		 -0.48 -2.27 -1.68 0.00 -0.48 0.00 -0.42 0.95 -1.92 -1.17 -0.45
NOPAT Less CapEx to Interest Expense		 -0.89 -1.38 -1.38 0.00 -0.89 0.00 -0.08 0.35 -1.22 -1.44 -0.81
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%

Financials Breakdown Chart

Key Financial Trends

Accuray’s latest quarter shows a mixed picture: revenue grew modestly year over year, but profitability remains under pressure and operating cash flow turned sharply negative. The balance sheet still carries substantial debt, and liquidity has tightened compared with a year ago.

  • Q3 2026 revenue rose to $104.8 million, up from $101.1 million in Q3 2025, showing modest top-line growth.
  • Gross profit improved to $25.3 million from $23.1 million a year ago, indicating the company preserved decent gross margin despite higher costs.
  • Cash and equivalents were still $38.1 million at quarter-end, giving the company some near-term liquidity.
  • Total equity improved to $41.7 million from $41.1 million in the prior-year quarter, but it remains relatively thin.
  • Depreciation and amortization remain meaningful non-cash add-backs, which helps reported earnings differ from cash generation.
  • Deferred revenue remains sizable at $90.3 million, supporting a backlog-like source of future revenue recognition.
  • Restructuring charges of $6.5 million weighed on results this quarter, suggesting ongoing efforts to reset the cost structure.
  • Accuray posted a $11.8 million net loss in Q3 2026, versus a $1.3 million loss in Q3 2025, so profitability deteriorated sharply.
  • Operating cash flow was negative $5.6 million in Q3 2026, after being positive $18.1 million in Q1 2026, showing uneven cash generation.
  • Total liabilities were $405.9 million versus only $41.7 million of equity, leaving the capital structure highly leveraged.

Looking at the recent trend: Accuray’s revenue has been relatively stable around the low-$100 million range per quarter, but margins have been volatile. Q4 2025 looked much better, with operating income of $4.2 million and net income of $1.1 million, but that improvement did not carry through consistently into 2026. In Q1 2026, the company actually generated positive operating cash flow of $12.2 million, yet Q2 and Q3 2026 both swung negative on cash from operations.

Balance sheet watchpoint: long-term debt was $134.0 million in Q3 2026, plus $11.2 million of short-term debt. That debt load, combined with recurring losses, makes execution important. The company’s inventory also remains high at $156.6 million, which can be a positive if demand is healthy, but it can also tie up cash if sales slow.

Bottom line: Accuray is still a company with a meaningful installed base and respectable revenue, but investors should focus on whether management can convert that into sustained operating profits and consistent positive cash flow. Right now, the trend is not yet strong enough to call the turnaround fully secure.

07/27/26 09:38 AM ETAI Generated. May Contain Errors.

Accuray Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Accuray's financial year ends in June. Their financial year 2025 ended on June 30, 2025.

Accuray's net income appears to be on a downward trend, with a most recent value of -$1.59 million in 2025, falling from -$40.21 million in 2015. The previous period was -$15.55 million in 2024. View Accuray's forecast to see where analysts expect Accuray to go next.

Accuray's total operating income in 2025 was $7.84 million, based on the following breakdown:
  • Total Gross Profit: $146.97 million
  • Total Operating Expenses: $139.13 million

Over the last 10 years, Accuray's total revenue changed from $379.80 million in 2015 to $458.51 million in 2025, a change of 20.7%.

Accuray's total liabilities were at $389.07 million at the end of 2025, a 8.1% decrease from 2024, and a 0.5% decrease since 2015.

In the past 10 years, Accuray's cash and equivalents has ranged from $57.42 million in 2025 to $119.77 million in 2016, and is currently $57.42 million as of their latest financial filing in 2025.

Over the last 10 years, Accuray's book value per share changed from 0.96 in 2015 to 0.79 in 2025, a change of -17.9%.


Related Companies

Financial statements for NASDAQ:ARAY last updated on 7/9/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Trump Takes Emergency Action - Plus Elon Musk's New Venture
Elon Musk has quietly launched a new venture - one that has nothing to do with rockets, EVs, or Neuralink. Tru...
Altimetry | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
SPCX Warning - and Worst News for Stocks in 50 Years
Goldman Sachs and Morgan Stanley are now predicting what could be the worst news for the U.S. stock market in ...
TradeSmith | Sponsoredtc pixel
Where to Put $100 Before Trump's New Tech Law Rolls Out
The Financial Times says a new tech law puts America 'on the verge of a financial revolution.' Yahoo Finance e...
Brownstone Research | Sponsoredtc pixel
Elon's new "super startup"
Adam O'Dell - the analyst who recommended Palantir before it became the top S&P 500 performer - has identified...
Banyan Hill Publishing | Sponsoredtc pixel